Fennec Pharmaceuticals Inc.
FENC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$637 | -$3,152 | -$1,165 | -$1,985 |
| Dep. & Amort. | $51 | $25 | $39 | $121 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,219 | $1,494 | $798 | $1,124 |
| Change in WC | $7,280 | -$3,210 | -$4,070 | $678 |
| Other Non-Cash | -$7,420 | $1,157 | $80 | -$1,412 |
| Operating Cash Flow | $1,493 | -$3,686 | -$4,318 | -$1,474 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$171 | -$198 | $370 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$9 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,920 | -$86 | -$11 | -$12,203 |
| Financing Cash Flow | $1,749 | -$284 | $359 | -$12,212 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3,242 | -$3,970 | -$3,959 | -$13,686 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,705 | $22,675 | $26,634 | $40,320 |
| End Cash | $21,947 | $18,705 | $22,675 | $26,634 |
| Free Cash Flow | $1,493 | -$3,686 | -$4,318 | -$1,474 |